Concept
September Options
10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE / Key Takeaways
"September brought new options for breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus a brain tumor scan and easier lung cancer treatment.\n\nSeptember 2026 was a busy month for the Food and Drug Administration (FDA), with new options for several cancers that have had few choices. Here's a plain-language guide to each decision, who it's for and what it could mean for your care. (For last month's list, see 6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You.)"
Related Ideas
- Treatment Findings10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · Key Takeaways
- Treatment Access10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · Key Takeaways
- Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 2. Hyrnuo as a First Treatment for HER2-Mutant Lung Cancer
- Bexlutry Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 6. Bexlutry for Neuroendocrine Tumors
- Bravnetsa Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 8. Bravnetsa for Neuroendocrine Tumors
- Pixclara Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 5. Pixclara Brain Tumor Scan
- Lyrfigtu Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 9. Lyrfigtu for FGFR2-Positive Bile Duct Cancer
- Treatment Results10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 10. Welireg Plus Lenvima for Advanced Kidney Cancer